Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ADAMTS5 | Q9UNA0 | 6/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31749265 | 1.00 | KMT2A (0.54) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL14007040 | 0.98 | KMT2A (0.51) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL20586242 | 0.94 | KMT2A (0.48) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL21096853 | 0.91 | MEN1 (0.44) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL14450381 | 0.91 | KMT2A (0.46) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL25446265 | 0.91 | MEN1 (0.44) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24510299 | 0.91 | MEN1 (0.44) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL25855706 | 0.91 | MEN1 (0.44) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL13227693 | 0.90 | KMT2A (0.45) | KMT2AMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL12972568 | 0.90 | MEN1 (0.45) | KMT2AMEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325683-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | SCRIPPS RESEARCH INST (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250320252-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | SCRIPPS RESEARCH INST (US) | 2025-10-16 | — | — | US | disclosed |
| US-12329823-B2 | Long-acting dual GIP/GLP-1 peptide conjugates and methods of use | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-06-17 | — | — | US | disclosed |
| US-20240148884-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | THE SCRIPPS RESEARCH INSTITUTE | 2024-05-09 | — | — | US | disclosed |
| CN-109153703-B | Immunomodulator | 百时美施贵宝公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-107207568-B | Immunomodulator | 百时美施贵宝公司 | 2021-12-10 | — | — | CN | disclosed |
| CN-107001424-B | Immunomodulator | 百时美施贵宝公司 | 2021-03-05 | — | — | CN | disclosed |
| CN-111051332-A | Immunomodulator | 百时美施贵宝公司 | 2020-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148884-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | GLP1R, GIPR, GCGR | KMT2A 2554/4885MEN1 1457/4885ALDH1A1 2672/4885 |
| US-20250325683-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | GLP1R, GIPR, GCGR | KMT2A 2554/4885MEN1 1457/4885ALDH1A1 2672/4885 |
| US-12329823-B2 | Long-acting dual GIP/GLP-1 peptide conjugates and methods of use | GLP1R, GIPR, GCGR | KMT2A 2554/4885MEN1 1457/4885ALDH1A1 2672/4885 |
| US-20250320252-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | GLP1R, GIPR, GCGR | KMT2A 2554/4885MEN1 1457/4885ALDH1A1 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.